Quick Answer
Genprex, Inc. reported Stockholders Equity of $7.96 million for the year ending 2025.
- Genprex, Inc. showed an increase of +391.4% in Stockholders Equity from 2024 to 2025.
- This data is from Genprex, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2015 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$41.9 thousand | Q2 2018: $12.59 million | Q3 2018: $10.48 million | Q1 2019: $7.25 million | Q2 2019: $5.33 million | Q3 2019: $3.53 million | Q1 2020: $23.94 million | Q2 2020: $24.51 million | Q3 2020: $22.98 million | Q1 2021: $50.42 million | Q2 2021: $47.68 million | Q3 2021: $45.17 million | Q1 2022: $37.02 million | Q2 2022: $32.41 million | Q3 2022: $27.49 million | Q1 2023: $18.48 million | Q2 2023: $12.05 million | Q3 2023: $12.31 million | Q1 2024: $8.76 million | Q2 2024: $4.35 million | Q3 2024: $1.66 million | Q1 2025: $3.87 million | Q2 2025: $1.39 million | Q3 2025: $767.8 thousand.
- Over the full 14 years of available data (2015 to 2025), Genprex, Inc.'s Stockholders Equity has grown by 1,922.1%.
- Historical annual values: Fiscal year 2025: $7.96 million | Fiscal year 2024: $1.62 million | Fiscal year 2023: $7.42 million | Fiscal year 2022: $22.27 million | Fiscal year 2022: $27.49 million | Fiscal year 2022: $32.41 million | Fiscal year 2022: $37.02 million | Fiscal year 2021: $41.28 million | Fiscal year 2020: $30.92 million | Fiscal year 2019: $3.02 million | Fiscal year 2018: $8.88 million | Fiscal year 2017: $428.6 thousand | Fiscal year 2016: $1.62 million | Fiscal year 2015: $393.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: